Navigation Links
Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium
Date:12/5/2008

REDWOOD CITY, Calif., Dec. 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from four studies at the 31st Annual San Antonio Breast Cancer Symposium, taking place December 10-14, 2008, at the Henry B. Gonzalez Convention Center. Two of the studies analyze Oncotype DX(R), the company's multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit as well as the likelihood of recurrence for women with early-stage breast cancer.

Following are details for each embargoed session (all times are Central Standard Time):

    -- Thursday, December 11, 2008, 4 p.m. - 4:15 p.m.
       Abstract #25
       Oral presentation (General Session 2): "GRB7-dependent pathways are
       potential therapeutic targets in triple-negative breast cancer"
       Presenter: Joseph Sparano, M.D., Montefiore-Einstein Cancer Center, New
       York
       Location: Exhibit Hall D

    -- Friday, December 12, 2008, 7 a.m. - 9 a.m.
       Abstract #2066
       Poster presentation (Poster Session II: Prognosis and Response
       Predictions: Biomarkers -- Methods): "Quantitative gene expression
       analysis using Oncotype DX in ductal carcinoma in situ that is adjacent
       to invasive ductal carcinoma"
       Presenter: Rick Baehner, M.D., Helen Diller Family Comprehensive Cancer
       Center at the University of California, San Francisco
       Location: Exhibit Hall B

    -- Friday, December 12, 2008, 5 p.m. - 7 p.m.
       Abstract #3049
       Poster presentation (Poster Session III: Tumor Cell and Molecular
       Biology: Hormonal Factors and Receptors): "Associations between
       estrogen receptor (ER) Alpha expression levels and ER genotypes"
       Presenter: Daniel Hayes, M.D., University of Michigan Health Sys
'/>"/>
SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
2. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
3. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
4. Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
5. Genomic Health to Present at Stephens Fall Investment Conference
6. Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
7. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
8. Transgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference
9. /C O R R E C T I O N -- Rosetta Genomics Ltd/
10. Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
11. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... In contrast to traditional LED lights ... colors, Valoya uses proprietary LED technology to incorporate their ... uniformity which is critical in low proximity installations. The ... throughout its lifetime which is up to four times ... "The investment cost was clearly higher when compared to ...
(Date:12/19/2014)... Egenix, Inc. is pleased to announce that ... Board, to succeed Donald Fresne ; Mr. Fresne has ... a member of the Board.  In recognition of the many ... over almost twenty years, the Board designated Mr. Fresne as ... established a Search Committee to find a suitable replacement with ...
(Date:12/17/2014)... Based on the revenues gained ... market is dominated by four major players contributing ... These players include GE Healthcare (U.K.), Siemens AG ... , Full Report Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html ... be attributed to its strong product portfolio, which ...
(Date:12/17/2014)... 2014 Once more, EMAAR has ... packaged waste water treatment plant to phase one of ... (KAEC). Two years ago Bioshaft successfully supplied and operated ... two residential towers with an occupancy of 900 residences. ... million gallons per day and was signed on September ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4
... a developer of sterile generic and specialty pharmaceutical products, ... A round of private financing. This financing was led ... very pleased that InnoPharma,s aggressive and well-managed growth over ... an outstanding investor, whose expertise and professional network will ...
... World-class investigators affiliated with US Oncology Research ... and displayed Dec. 6-10 at the Henry B. Gonzales ... Cancer Symposium ( SABCS ), an international scientific symposium ... in breast cancer. (Logo: http://photos.prnewswire.com/prnh/20110912/DA65711LOGO ) ...
... 2011  VIVUS, Inc. (NASDAQ: VVUS ) today announced ... of the company at the 2011 Deutsche Bank BioFEST Conference. ... Four Seasons Hotel, Boston, MA on Tuesday, December 6, 2011 ... of the presentation will be available at http://ir.vivus.com .About ...
Cached Biology Technology:InnoPharma Completes $15 Million Series A Financing 2US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium 2US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium 3US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium 4VIVUS to Present at the Deutsche Bank BioFEST Conference 2VIVUS to Present at the Deutsche Bank BioFEST Conference 3
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced ... (GCP) audit to confirm its adherence to current ... accomplishment enables HITLAB to conduct regulated smart device ... principles for patient safety and research quality. ... access, quality, and delivery with innovative technology," said ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... syndrome (SARS), by its very name, indicates a disease ... brain tissue, causing significant central nervous system problems, according ... Clinical Infectious Diseases, now available online. , SARS, a ... reported in Asia in February of 2003. The disease ...
... evidence that the retina actively seeks novel features in ... to seek the unusual while ignoring the commonplace. The ... Nature on their finding that this principle of novelty-detection ... for novelty begins in the eye itself," says Markus ...
... that carbon nanotubes make an ideal scaffold for the growth ... doctors treat broken bones, allowing them to simply inject a ... The report appears in the June 14 issue of the ... world's largest scientific society. , The success of a bone ...
Cached Biology News:New study shows SARS can infect brain tissue 2Retina adapts to seek the unexpected, ignore the commonplace 2Nanotubes inspire new technique for healing broken bones 2Nanotubes inspire new technique for healing broken bones 3
Mouse monoclonal [LPL4A.1] to Plastin L ( Abpromise for all tested applications). SwissProtID: P13796...
Component of HyperMu™ Insertion Kit...
Recombinant Rhesus Macaque IFN-alpha...
chk 1 kinase...
Biology Products: